![GenSight Biologics Reports Topline Results from REFLECT Phase III Clinical Trial, Confirming LUMEVOQ® Efficacy Including Better Efficacy with Bilateral Treatment | BioSpace GenSight Biologics Reports Topline Results from REFLECT Phase III Clinical Trial, Confirming LUMEVOQ® Efficacy Including Better Efficacy with Bilateral Treatment | BioSpace](https://mms.businesswire.com/media/20210629006120/en/888747/4/Gensight-1.jpg)
GenSight Biologics Reports Topline Results from REFLECT Phase III Clinical Trial, Confirming LUMEVOQ® Efficacy Including Better Efficacy with Bilateral Treatment | BioSpace
Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments: A first step to assess the feasibility of establishing an individual patient data sharing platform | PLOS Neglected Tropical
![Understanding Antiarrhythmic Drug Efficacy for the Clinical Practitioner: There Is More than Meets the Eye - The American Journal of Medicine Understanding Antiarrhythmic Drug Efficacy for the Clinical Practitioner: There Is More than Meets the Eye - The American Journal of Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/c37e527b-cb2f-432e-98a7-a69d2ecd9e82/gr1.jpg)
Understanding Antiarrhythmic Drug Efficacy for the Clinical Practitioner: There Is More than Meets the Eye - The American Journal of Medicine
![Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response | Nature Reviews Drug Discovery Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd3501/MediaObjects/41573_2011_Article_BFnrd3501_Fig1_HTML.jpg)
Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response | Nature Reviews Drug Discovery
![Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study - ScienceDirect Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332222001172-ga1.jpg)